SHH:688089
Cabio Biotech (Wuhan) Co., Ltd. · SHH · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 12:44 UTC
Last close
n/aCNY
Market data
8.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth11.7%49 of 100, above its sector
- Returns on capital8.8%74 of 100, above its sector
- Marginsn/anot placed
- Price8.9x69 of 100, above its sector
- Safety4.4484 of 100, above its sector
- What it pays out2.8%63 of 100, above its sector
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Nothing in our coverage is near enough to this company to compare it with, so we are not comparing it with anything.
Nothing is drawn in its place. The other lenses are unaffected.
We hold no market value we can defend for SHH:688089, so there is no size to find companies near.